Celsion - 21 Year Stock Price History | CLSN

Historical daily share price chart and data for Celsion since 1999 adjusted for splits. The latest closing stock price for Celsion as of November 27, 2020 is 0.57.
  • The all-time high Celsion stock closing price was 8826.30 on March 02, 2000.
  • The Celsion 52-week high stock price is 6.50, which is 1040.4% above the current share price.
  • The Celsion 52-week low stock price is 0.43, which is 24.6% below the current share price.
  • The average Celsion stock price for the last 52 weeks is 1.43.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Celsion Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.4135 1.7300 5.2600 0.4720 0.5735 -66.46%
2019 1.8717 1.6700 2.4700 1.0801 1.7100 21.28%
2018 2.4829 2.8200 3.3200 1.3600 1.4100 -47.39%
2017 3.0280 4.4118 7.1429 1.2800 2.6800 -37.03%
2016 17.1710 27.0308 27.0308 4.2563 4.2563 -84.17%
2015 32.1009 33.4734 44.1176 23.1092 26.8908 -17.60%
2014 44.6181 56.8627 64.0056 32.0728 32.6331 -40.10%
2013 104.5111 522.5312 589.3446 48.2191 54.4818 -89.45%
2012 224.9077 108.4142 556.5683 103.3717 516.2281 381.76%
2011 177.5145 138.6693 266.6233 106.5233 107.1536 -17.07%
2010 213.9821 195.4040 342.8914 126.6933 129.2146 -37.31%
2009 214.6009 174.5973 326.5032 129.2146 206.1130 48.64%
2008 252.0075 204.8524 409.7048 126.0630 138.6693 -25.93%
2007 301.7050 152.5363 447.5237 147.4937 187.2036 56.32%
2006 203.7777 255.1501 367.4737 113.4567 119.7599 -53.06%
2005 354.4501 510.3001 548.1001 245.7001 255.1501 -52.63%
2004 809.3627 1200.1503 1719.9004 387.4501 538.6501 -56.49%
2003 779.2502 387.4501 1417.5003 378.0001 1237.9503 204.65%
2002 478.6501 699.3001 926.1002 321.3001 406.3501 -34.85%
2001 851.1098 1124.5502 2475.9005 387.4501 623.7001 -34.00%
2000 3184.0132 2835.0006 8826.3019 945.0002 945.0002 -65.99%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.020B $0.001B
Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, North Shore Long Island Jewish Health System.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.187B 10.14
Amgen (AMGN) United States $128.258B 13.41
CSL (CSLLY) Australia $104.516B 0.00
Gilead Sciences (GILD) United States $74.585B 9.92
Vertex Pharmaceuticals (VRTX) United States $56.714B 26.37
Regeneron Pharmaceuticals (REGN) United States $54.240B 19.24
Illumina (ILMN) United States $44.381B 61.04
Moderna (MRNA) United States $43.204B 0.00
Biogen (BIIB) United States $37.201B 6.61
Seagen (SGEN) United States $29.832B 78.79
Alexion Pharmaceuticals (ALXN) United States $26.903B 10.72
BeiGene (BGNE) Cayman Islands $23.985B 0.00
BioNTech SE (BNTX) Germany $23.748B 0.00
Genmab (GMAB) Denmark $23.537B 27.84
Genmab (GNMSF) Denmark $22.400B 5.16
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $17.774B 0.00
Exact Sciences (EXAS) United States $17.430B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.674B 59.44
Horizon Therapeutics Public (HZNP) Ireland $15.207B 21.74
Alnylam Pharmaceuticals (ALNY) United States $14.575B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.187B 94.16
ARGENX SE-ADR (ARGX) Netherlands $12.480B 0.00
Bio-Techne Corp (TECH) United States $11.650B 74.51
Mirati Therapeutics (MRTX) United States $11.336B 0.00
Guardant Health (GH) United States $11.261B 0.00
QIAGEN (QGEN) Netherlands $10.761B 24.23
Sarepta Therapeutics (SRPT) United States $10.710B 0.00
Repligen (RGEN) United States $9.547B 135.40
ACADIA Pharmaceuticals (ACAD) United States $8.881B 0.00
Ascendis Pharma (ASND) Denmark $8.661B 0.00
Galapagos (GLPG) Belgium $7.892B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.772B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.315B 0.00
Denali Therapeutics (DNLI) United States $7.269B 0.00
Acceleron Pharma (XLRN) United States $6.854B 0.00
Novavax (NVAX) United States $6.532B 0.00
Adaptive Biotechnologies (ADPT) United States $6.268B 0.00
Amicus Therapeutics (FOLD) United States $5.931B 0.00
Blueprint Medicines (BPMC) United States $5.870B 19.43
Exelixis (EXEL) United States $5.811B 39.02
Halozyme Therapeutics (HALO) United States $5.561B 257.13
SWEDISH ORP BIO (BIOVF) Sweden $5.208B 14.23
Reata Pharmaceuticals (RETA) United States $5.146B 0.00
NeoGenomics (NEO) United States $5.075B 1523.67
Fate Therapeutics (FATE) United States $4.984B 0.00
China Biologic Products (CBPO) China $4.674B 30.29
Twist Bioscience (TWST) United States $4.450B 0.00
Emergent Biosolutions (EBS) United States $4.262B 13.98
Insmed (INSM) United States $3.930B 0.00
Arena Pharmaceuticals (ARNA) United States $3.810B 0.00
Legend Biotech (LEGN) United States $3.760B 0.00
Vir Biotechnology (VIR) United States $3.619B 0.00
MorphoSys AG (MOR) Germany $3.532B 127.86
Deciphera Pharmaceuticals (DCPH) United States $3.518B 0.00
Eidos Therapeutics (EIDX) United States $3.430B 0.00
Alkermes (ALKS) Ireland $2.933B 28.80
Bluebird Bio (BLUE) United States $2.869B 0.00
Global Blood Therapeutics (GBT) United States $2.710B 0.00
Seres Therapeutics (MCRB) United States $2.682B 0.00
Beam Therapeutics (BEAM) United States $2.591B 0.00
Zymeworks (ZYME) Canada $2.225B 0.00
Intellia Therapeutics (NTLA) United States $2.119B 0.00
I-Mab (IMAB) China $2.111B 0.00
Viela Bio (VIE) United States $2.073B 0.00
UniQure (QURE) Netherlands $2.069B 0.00
Intra-Cellular Therapies (ITCI) United States $2.051B 0.00
PHARMA MAR SA (PHMMF) Spain $1.921B 0.00
Editas Medicine (EDIT) United States $1.836B 0.00
Sorrento Therapeutics (SRNE) United States $1.814B 0.00
Amarin (AMRN) Ireland $1.799B 0.00
Mesoblast (MESO) Australia $1.793B 0.00
Inovio Pharmaceuticals (INO) United States $1.760B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.754B 0.00
Mersana Therapeutics (MRSN) United States $1.705B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.674B 0.00
Revance Therapeutics (RVNC) United States $1.631B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Arcus Biosciences (RCUS) United States $1.582B 0.00
NGM Biopharmaceuticals (NGM) United States $1.572B 0.00
Scholar Rock Holding (SRRK) United States $1.504B 0.00
Alcobra (ARCT) United States $1.485B 0.00
Zealand Pharma (ZEAL) Denmark $1.444B 0.00
Ligand Pharmaceuticals (LGND) United States $1.406B 36.42
Precigen (PGEN) United States $1.387B 0.00
Sangamo Therapeutics (SGMO) United States $1.382B 0.00
Myriad Genetics (MYGN) United States $1.370B 0.00
Adverum Biotechnologies (ADVM) United States $1.346B 0.00
REGENXBIO (RGNX) United States $1.334B 0.00
Coherus BioSciences (CHRS) United States $1.300B 8.60
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Athenex (ATNX) United States $1.279B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.234B 0.00
Epizyme (EPZM) United States $1.204B 0.00
Heska (HSKA) United States $1.195B 0.00
Cytokineticsorporated (CYTK) United States $1.174B 0.00
Genetron Holdings (GTH) China $1.173B 0.00
Travere Therapeutics (TVTX) United States $1.164B 0.00
Vericel (VCEL) United States $1.134B 0.00
Codexis (CDXS) United States $1.059B 0.00
Pliant Therapeutics (PLRX) United States $1.056B 0.00
Alector (ALEC) United States $1.053B 0.00
Morphic Holding (MORF) United States $1.014B 0.00
Northwest Biotherapeutics (NWBO) United States $1.014B 0.00
Cellectis S.A (CLLS) France $0.953B 0.00
Arvinas (ARVN) United States $0.950B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.945B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.900B 0.00
Protagonist Therapeutics (PTGX) United States $0.885B 0.00
Frequency Therapeutics (FREQ) United States $0.879B 0.00
Castle Biosciences (CSTL) United States $0.868B 0.00
Celldex Therapeutics (CLDX) United States $0.861B 0.00
Compugen (CGEN) Israel $0.844B 0.00
NantKwest (NK) United States $0.819B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 17.19
Cardiff Oncology (CRDF) United States $0.753B 0.00
Cara Therapeutics (CARA) United States $0.750B 0.00
MiMedx (MDXG) United States $0.726B 0.00
Albireo Pharma (ALBO) United States $0.705B 0.00
Five Prime Therapeutics (FPRX) United States $0.702B 0.00
Kadmon Holdings (KDMN) United States $0.696B 0.00
MannKind (MNKD) United States $0.686B 0.00
AnaptysBio (ANAB) United States $0.675B 0.00
Agenus (AGEN) United States $0.667B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.662B 33.64
VBI Vaccines (VBIV) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Sutro Biopharma (STRO) United States $0.637B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.635B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.626B 0.00
Precision BioSciences (DTIL) United States $0.604B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.600B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
IVERIC Bio (ISEE) United States $0.564B 0.00
Geron (GERN) United States $0.562B 0.00
Anika Therapeutics (ANIK) United States $0.544B 73.56
Aquinox Pharmaceuticals (NLTX) United States $0.534B 0.00
MeiraGTx Holdings (MGTX) United States $0.527B 0.00
Avid Bioservices (CDMO) United States $0.497B 0.00
Forte Biosciences (FBRX) United States $0.490B 0.00
Cel-Sci (CVM) United States $0.482B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.476B 0.00
Merus (MRUS) Netherlands $0.471B 0.00
Dynavax Technologies (DVAX) United States $0.468B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.466B 0.00
WAVE Life Sciences (WVE) Singapore $0.449B 0.00
Prothena (PRTA) Ireland $0.446B 0.00
Puma Biotechnology (PBYI) United States $0.439B 0.00
Spero Therapeutics (SPRO) United States $0.433B 0.00
Amryt Pharma (AMYT) United Kingdom $0.430B 0.00
UROGEN PHARMA (URGN) United States $0.426B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.417B 0.00
Kala Pharmaceuticals (KALA) United States $0.409B 0.00
Innate Pharma S.A (IPHA) France $0.409B 0.00
Starpharma Holdings (SPHRY) Australia $0.401B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.397B 0.00
Affimed (AFMD) Germany $0.395B 0.00
Clovis Oncology (CLVS) United States $0.392B 0.00
Cue Biopharma (CUE) United States $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.376B 17.71
AC Immune SA (ACIU) Switzerland $0.373B 0.00
Trevena (TRVN) United States $0.367B 0.00
Syros Pharmaceuticals (SYRS) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.363B 0.00
ANI Pharmaceuticals (ANIP) United States $0.362B 9.20
XOMA (XOMA) United States $0.360B 0.00
Selecta Biosciences (SELB) United States $0.353B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.350B 0.00
Athersys (ATHX) United States $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.340B 0.00
Arbutus Biopharma (ABUS) United States $0.320B 0.00
ChromaDex (CDXC) United States $0.300B 0.00
Kamada (KMDA) Israel $0.295B 13.79
CorMedix Inc (CRMD) United States $0.294B 0.00
PDL BioPharma (PDLI) United States $0.292B 0.00
Verastem (VSTM) United States $0.289B 0.00
NextCure (NXTC) United States $0.281B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.278B 0.00
IBio (IBIO) United States $0.266B 0.00
DBV Technologies S.A (DBVT) France $0.260B 0.00
Fortress Biotech (FBIO) United States $0.245B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
TELA Bio (TELA) United States $0.241B 0.00
Pluristem Therapeutics (PSTI) Israel $0.239B 0.00
Aptinyx (APTX) United States $0.216B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.198B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.194B 0.00
AquaBounty Technologies (AQB) United States $0.187B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Theratechnologies (THTX) Canada $0.182B 0.00
Eton Pharmaceuticals (ETON) United States $0.182B 0.00
Aptevo Therapeutics (APVO) United States $0.182B 0.00
Cerecor (CERC) United States $0.181B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 0.00
Bellus Health (BLU) Canada $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.173B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Checkpoint Therapeutics (CKPT) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.162B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
VolitionRX (VNRX) United States $0.161B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.159B 0.00
Kindred Biosciences (KIN) United States $0.158B 0.00
Dyadic (DYAI) United States $0.156B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.155B 0.00
Oncobiologics (OTLK) United States $0.154B 0.00
SESEN BIO, INC (SESN) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
Idera Pharmaceuticals (IDRA) United States $0.141B 0.00
Abeona Therapeutics (ABEO) United States $0.139B 0.00
Celyad SA (CYAD) Belgium $0.134B 0.00
Lumos Pharma (LUMO) United States $0.131B 0.00
Protalix BioTherapeutics (PLX) Israel $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Gritstone Oncology (GRTS) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.125B 0.00
Exicure (XCUR) United States $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Orgenesis (ORGS) United States $0.117B 243.00
Cocrystal Pharma (COCP) United States $0.117B 0.00
Aytu Bioscience (AYTU) United States $0.115B 0.00
Applied Genetic Technologies (AGTC) United States $0.111B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.110B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.108B 0.00
Cogent Biosciences (COGT) United States $0.108B 0.00
Windtree Therapeutics (WINT) United States $0.107B 0.00
DiaMedica Therapeutics (DMAC) United States $0.105B 0.00
Palatin Technologies (PTN) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
Prometic Life Sciences (LMNL) Canada $0.094B 0.00
Novogen (KZIA) Australia $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.092B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
Synlogic (SYBX) United States $0.085B 0.00
Curis (CRIS) United States $0.081B 0.00
AnPac Bio-Medical Science (ANPC) China $0.080B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 33.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.063B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.054B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
Edesa Biotech (EDSA) Canada $0.050B 0.00
Seelos Therapeutics (SEEL) United States $0.048B 0.00
Vaccinex (VCNX) United States $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.042B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Titan Pharmaceuticals (TTNP) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
OvaScience (MLND) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Spherix (AIKI) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
MedAvail Holdings (MDVL) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00